Newsletter Insights — independent newsletter & sponsorship data across 41K+ newsletters
Browse all →
COVID Intel - by William Makis (McGill Medicine)
substackHealth
Cutting Edge Cancer Research, Repurposed Drugs in Cancer, Ivermectin, Mebendazole, Fenbendazole. Content is for informational purposes only. Entirely donation based. None of the information constitutes medical advice (see your doctor as needed).
Interested in sponsoring COVID Intel - by William Makis (McGill Medicine)?
Enter your email and we'll send your inquiry to the Newsletter Insights team.
Need a wider shortlist than just COVID Intel - by William Makis (McGill Medicine)?
Tell us your brand and audience. We send back 10-15 newsletters matched to your brief, with sponsor history and CPM ranges per placement.
$300·2-3 working days·refunded if we can't deliver
See what's includedDownload PDF Media Kit
COVID Intel - by William Makis (McGill Medicine)'s metrics, benchmarks, and sponsor data in one document
